757 related articles for article (PubMed ID: 27744485)
1. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.
Lánczky A; Nagy Á; Bottai G; Munkácsy G; Szabó A; Santarpia L; Győrffy B
Breast Cancer Res Treat; 2016 Dec; 160(3):439-446. PubMed ID: 27744485
[TBL] [Abstract][Full Text] [Related]
2. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
Madden SF; Clarke C; Gaule P; Aherne ST; O'Donovan N; Clynes M; Crown J; Gallagher WM
Breast Cancer Res; 2013; 15(4):R52. PubMed ID: 23820017
[TBL] [Abstract][Full Text] [Related]
3. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
[TBL] [Abstract][Full Text] [Related]
4. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
Madhavan D; Peng C; Wallwiener M; Zucknick M; Nees J; Schott S; Rudolph A; Riethdorf S; Trumpp A; Pantel K; Sohn C; Chang-Claude J; Schneeweiss A; Burwinkel B
Carcinogenesis; 2016 May; 37(5):461-70. PubMed ID: 26785733
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
6. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
Jayavelu ND; Bar N
BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of deregulated microRNAs in uveal melanomas.
Falzone L; Romano GL; Salemi R; Bucolo C; Tomasello B; Lupo G; Anfuso CD; Spandidos DA; Libra M; Candido S
Mol Med Rep; 2019 Apr; 19(4):2599-2610. PubMed ID: 30816460
[TBL] [Abstract][Full Text] [Related]
9. Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
Lee E; Ito K; Zhao Y; Schadt EE; Irie HY; Zhu J
Bioinformatics; 2016 Jan; 32(1):96-105. PubMed ID: 26358730
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
11. An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer.
Zhou X; Wang X; Huang Z; Xu L; Zhu W; Liu P
J Exp Clin Cancer Res; 2014 Nov; 33(1):94. PubMed ID: 25373603
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
14. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
15. Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
Kim SY; Kawaguchi T; Yan L; Young J; Qi Q; Takabe K
Ann Surg Oncol; 2017 Oct; 24(10):2943-2949. PubMed ID: 28766230
[TBL] [Abstract][Full Text] [Related]
16. Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
Kawaguchi T; Yan L; Qi Q; Peng X; Edge SB; Young J; Yao S; Liu S; Otsuji E; Takabe K
Ann Surg Oncol; 2018 Dec; 25(13):4037-4046. PubMed ID: 30311168
[TBL] [Abstract][Full Text] [Related]
17. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Chandrashekar DS; Bashel B; Balasubramanya SAH; Creighton CJ; Ponce-Rodriguez I; Chakravarthi BVSK; Varambally S
Neoplasia; 2017 Aug; 19(8):649-658. PubMed ID: 28732212
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
19. Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
Jonsdottir K; Janssen SR; Da Rosa FC; Gudlaugsson E; Skaland I; Baak JP; Janssen EA
PLoS One; 2012; 7(11):e48692. PubMed ID: 23144930
[TBL] [Abstract][Full Text] [Related]
20. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
